PRP, Stem Cells and Exosome Add-Ons With a Hair Transplant in Turkey: What Is Evidence-Based?

Patients considering a hair transplant in Turkey may be offered platelet-rich plasma (PRP), stem-cell-derived treatments or exosome products as additional treatments. These add-ons are often promoted as ways to support graft survival, earlier growth or hair density, but the evidence is not equally strong for all three options.

In Short

• PRP has the strongest clinical evidence of these three add-ons, but evidence specifically alongside hair transplantation is limited and protocols vary.
• Stem-cell-derived treatments have encouraging early findings but are not standardized or established as routine hair-transplant care.
• Exosome treatments remain investigational, with limited clinical validation, no established transplant protocol and no FDA-approved exosome products.
• No add-on can be presented as a guaranteed way to improve graft survival, speed growth or produce permanent regrowth.

This article explains what is known, what remains uncertain and which questions international patients should ask before paying for an add-on. Individual suitability should be assessed by a qualified physician after review of the diagnosis, medical history and treatment goals.

What are hair transplant add-ons?

A hair transplant moves follicles from a donor area to areas affected by hair loss. An add-on is an additional biological or regenerative treatment offered before, during or after transplantation. Its proposed purpose is usually to support the scalp environment or improve the appearance of existing and transplanted hair.

PRP, stem-cell-derived treatments and exosomes are not interchangeable. They differ in source, preparation, biological content, regulation and level of clinical evidence. A clinic should explain exactly which product or procedure it offers rather than relying on broad terms such as “regenerative therapy” or “cell therapy.”

PRP with hair transplantation: the most evidence-supported option

What is PRP?

PRP is prepared from a patient’s own blood. A blood sample is processed to create a platelet-concentrated preparation, which may be injected into selected scalp areas or applied in connection with a hair transplant. PRP preparation methods, concentrations, administration techniques and treatment schedules vary between clinics and studies.

There is no single universally accepted PRP preparation method, dose, injection schedule or timing protocol for use with hair transplantation. This makes direct comparison of study results difficult.

What does the research show?

PRP currently has the strongest clinical evidence among the three add-ons discussed here. A 2025 systematic review of PRP used as an adjunct to hair transplantation identified three controlled studies involving 217 patients. The results generally favored PRP for at least one measured outcome, such as hair density, graft survival or earlier visible growth. However, the studies differed substantially in their protocols, outcome measures and follow-up periods.

PRP may therefore be a useful adjunct for some patients, but the evidence does not establish a guaranteed improvement in every transplant. Long-term evidence is also limited. Research on PRP for androgenetic alopecia more broadly suggests possible improvements in hair density and reduced hair loss, but conclusions are limited by heterogeneity, publication bias and study-quality concerns.

In practical terms, PRP can reasonably be described as a potentially helpful, protocol-dependent add-on. It should not be presented as a guaranteed way to achieve better graft survival, faster growth or permanent regrowth.

Stem-cell-derived treatments: encouraging but not yet routine

What does “stem cell” mean in this context?

“Stem-cell treatment” can describe several different interventions. Studies may use different cell sources, processing methods, concentrations, delivery techniques and dosing schedules. Some approaches involve cells or cell-derived preparations, while others use tissue fractions or signaling products associated with regenerative activity.

Because these approaches are not standardized, a clinic’s use of the term “stem cells” does not by itself explain what treatment is being offered. Patients should request the exact name of the product or preparation, its source, how it is processed and whether it has been evaluated in controlled clinical research.

What does the evidence show?

Systematic reviews of randomized studies have reported potentially favorable effects from some autologous stem-cell-derived interventions for androgenetic alopecia. Early studies have examined outcomes such as hair regeneration or density and have produced encouraging findings.

Nevertheless, the evidence is still developing. The interventions differ widely, and some reported effects may be temporary. Long-term durability, optimal dosing, comparative effectiveness and appropriate patient selection remain uncertain. Available research does not support describing all stem-cell-derived treatments as established or equivalent.

For patients considering a hair transplant in Turkey, stem-cell-derived treatment should be approached as an emerging adjunct rather than a routine, evidence-established component of transplantation. A physician should explain whether the specific intervention has been studied in combination with hair transplantation or only in other hair-loss settings.

Exosome treatments: a promising concept that remains investigational

What are exosomes?

Exosomes are small extracellular vesicles involved in cell-to-cell communication. They may carry signaling molecules, and laboratory research has created interest in their possible role in tissue repair and hair biology. Biological rationale, however, is not the same as proven clinical effectiveness.

How strong is the clinical evidence?

Clinical research on exosome and extracellular-vesicle treatments for hair loss remains limited. Products are not standardized, and studies may differ in source material, preparation, concentration, administration method and quality controls. There is currently no well-established exosome protocol for use with hair transplantation.

The U.S. Food and Drug Administration states that there are no FDA-approved exosome products. It also warns that unapproved regenerative medicine products, including some stem-cell and exosome products, may pose safety risks. Treatment offered outside the United States is not overseen by the FDA, so international patients should not assume that a product has been evaluated simply because it is offered by a clinic abroad.

Exosomes should therefore be considered experimental or investigational in this setting. Claims that they guarantee superior graft survival, faster growth or permanent regrowth are not supported by current evidence.

Comparison: PRP, stem cells and exosomes

Who might be considered for an add-on?

There is no single add-on that is suitable for every hair transplant patient. A qualified physician should first confirm the cause and pattern of hair loss, evaluate the donor area and assess whether transplant goals are realistic. The decision may also depend on the preparation method, available evidence and the patient’s willingness to accept uncertainty.

Patients should be particularly cautious if an add-on is recommended without a clear explanation of what it contains, how it is prepared, how it will be administered or what evidence supports its use. The fact that a treatment is described as “natural,” “autologous” or “regenerative” does not automatically establish its safety or effectiveness.

What to ask a clinic in Turkey before treatment

International patients may have less opportunity for in-person consultations and follow-up, making advance questions especially important. Consider asking:

• What exactly is the proposed add-on, and is it PRP, a cell-derived preparation or an exosome product?
• Has this specific protocol been studied alongside hair transplantation, or only in general hair-loss research?
• What preparation method, dose and treatment schedule will be used?
• What realistic outcome can be expected, and which outcomes are not established?
• What are the known and uncertain risks of the product or procedure?
• Who will assess my suitability and perform or supervise the treatment?
• What follow-up is included after returning home?
• What documentation is available about the product’s source, processing and regulatory status?

A responsible consultation should distinguish between evidence from controlled clinical studies, early research and marketing claims. Be cautious if a clinic promises guaranteed graft survival, unusually rapid growth or superior results solely because an add-on is included.

Preparation, procedure and follow-up

Preparation depends on the specific add-on and the hair transplant plan. Before travelling, patients should receive a clear medical consultation and disclose relevant health information, current medications and previous hair-loss treatments to the physician. The clinic should explain whether the add-on is performed before, during or after transplantation and whether more than one session is proposed.

PRP generally involves collecting and processing the patient’s blood before administration to the scalp or transplant area. Stem-cell-derived and exosome procedures vary considerably, so the exact steps cannot be assumed from the treatment name alone. Patients should ask for a written description of the planned procedure rather than relying on promotional terminology.

Aftercare instructions should be provided by the treating team. Because protocols differ, patients should follow the clinic’s specific guidance about scalp care, appointments and contact after returning home. It is sensible to ask who to contact if a concern develops after travel.

Risks and limitations

Every medical procedure and biological product requires appropriate medical assessment and oversight. Risks and uncertainties may differ according to the product, preparation method and injection or application technique. For less-established products, important concerns include uncertainty about product quality, consistency, clinical effectiveness and longer-term effects.

Evidence limitations are also important. Small studies, different protocols, inconsistent outcome measures and short follow-up make it difficult to know how much benefit a particular add-on provides. An improvement reported in one study may not be reproduced by another clinic using a different preparation.

Patients travelling abroad should also consider the practical implications of limited continuity of care and the need to arrange follow-up after returning home. A physician should explain both potential benefits and uncertainties before treatment.

What is the most evidence-based choice?

Among PRP, stem-cell-derived treatments and exosomes, PRP currently has the strongest clinical support. Even so, evidence for PRP specifically combined with hair transplantation is limited and inconsistent enough that it should be described as a possible adjunct, not a guaranteed enhancement.

Stem-cell-derived treatments may be promising, but their evidence base is less standardized and their long-term benefits remain uncertain. Exosome treatments have the least established clinical position of the three and should be regarded as investigational, particularly when marketed with broad promises.

Frequently asked questions

Can PRP guarantee better graft survival?

No. Some controlled studies suggest possible benefits for graft survival, density or earlier growth, but the evidence is limited and does not establish a guaranteed outcome.

Are stem-cell treatments approved for hair transplantation?

Approval and regulation depend on the specific product, procedure and country. Stem-cell-derived interventions vary widely, and current research is not sufficient to treat all such therapies as established routine care. Ask the clinic for precise regulatory and clinical information about the proposed treatment.

Are exosomes FDA-approved?

The FDA states that there are currently no FDA-approved exosome products. Treatment offered in Turkey is not overseen by the FDA, so patients should seek clear information about product sourcing, regulatory status and safety monitoring.

Should every hair transplant patient add PRP, stem cells or exosomes?

No. Add-ons are not automatically necessary or suitable for every patient. A qualified physician should assess the diagnosis, donor area, treatment plan, medical history and evidence for the specific protocol.

Explore our Hair Transplant services in Turkey for an overview of treatment options and individual assessment.

Medical References

1. Efficacy of Platelet-Rich Plasma as an Adjunct to Hair Transplantation: A Systematic Review. PubMed; Cureus.
2. The Role of Platelet-Rich Plasma in Androgenetic Alopecia: A Systematic Review. PubMed; Journal of Cosmetic Dermatology.
3. Autologous Stem Cell-derived Therapies for Androgenetic Alopecia: A Systematic Review of Randomized Control Trials on Efficacy, Safety, and Outcomes. PubMed; Plastic and Reconstructive Surgery–Global Open; American Society of Plastic Surgeons.
4. Adjunctive Regenerative Therapies in Hair Transplantation: A Comprehensive Review of Platelet-Rich Plasma, Exosomes, and Emerging Methods. PubMed.
5. Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. U.S. Food and Drug Administration.